Načítá se...
Cytokine storm in COVID‐19 and parthenolide: Preclinical evidence
A group of patients with pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) were reported from China in December 2019. Although several antiviral drugs are widely tested, none of them has been approved as specific antiviral therapy for coronavirus disease 2019 (COVID‐19...
Uloženo v:
| Vydáno v: | Phytother Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300884/ https://ncbi.nlm.nih.gov/pubmed/32472655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.6776 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|